Pure Global

TROPONIN - ANVISA Registration 81246986892

Access comprehensive regulatory information for TROPONIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81246986892 and manufactured by QUIDEL CARDIOVASCULAR INC.,. The registration is held by ORTHO CLINICAL DIAGNÓSTICS DO BRASIL PRODUTOS PARA SAÚDE LTDA with validity until Feb 14, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BODITECH MED INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81246986892
2 Related Devices
Registration Details
ANVISA Registration Number: 81246986892
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Related Devices (2)

Família Quidel TriageTrue High Sensitivity Troponin I Test and Controls
Risk Class III

Registration Details

81246986892

25351687148202391

21921393000146

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Feb 14, 2024

14/02/2034

09/18/2025 19:00:01

Família Quidel TriageTrue High Sensitivity Troponin I Test and Controls
Risk Class III

Registration Details

81246986892

25351687148202391

21921393000146

Dates and Status

Feb 14, 2024

14/02/2034

09/18/2025 19:00:01